Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.55B
| $28.4M | 0.02% |
741,861
-166,928
| -18% | -$6.46M |
|
677
CALL
Starbucks
SBUX
$120B
| $28.3M | 0.02% |
498,300
-68,800
| -12% | -$3.64M |
|
|
ORBK
678
DELISTED
Orbotech Ltd
ORBK
| $28.3M | 0.02% |
475,397
+435,547
| +1,093% | +$27.2M |
|
|
MRO
679
DELISTED
Marathon Oil Corporation
MRO
| $28.2M | 0.02% |
1,211,015
-205,509
| -15% | -$4.3M |
|
|
DRE
680
DELISTED
Duke Realty Corp.
DRE
| $28.1M | 0.02% |
991,532
+57,355
| +6% | +$1.64M |
|
681
IQVIA
IQV
$39.3B
| $28.1M | 0.02% |
216,569
+59,266
| +38% | +$7.12M |
|
682
Entergy
ETR
$50B
| $28.1M | 0.02% |
692,128
-160,102
| -19% | -$6.62M |
|
|
CZR
683
CALL
DELISTED
Caesars Entertainment Corporation
CZR
| $28.1M | 0.02% |
2,737,300
+2,688,300
| +5,486% | +$28.3M |
|
684
CALL
Vertex Pharmaceuticals
VRTX
$126B
| $28M | 0.02% |
145,500
+22,400
| +18% | +$3.99M |
|
685
CALL
Sherwin-Williams
SHW
$89.8B
| $28M | 0.02% |
184,800
-2,700
| -1% | -$400K |
|
686
Ulta Beauty
ULTA
$24.3B
| $28M | 0.02% |
99,308
+19,503
| +24% | +$4.97M |
|
687
Tyson Foods
TSN
$20.4B
| $27.9M | 0.02% |
469,222
-26,693
| -5% | -$1.67M |
|
688
CALL
Twilio
TWLO
$36.6B
| $27.9M | 0.02% |
323,700
+122,600
| +61% | +$8.96M |
|
|
689
Weyerhaeuser
WY
$18.4B
| $27.9M | 0.02% |
864,616
-12,408,760
| -93% | -$431M |
|
|
NLSN
690
DELISTED
Nielsen Holdings plc
NLSN
| $27.8M | 0.02% |
1,005,577
+546,777
| +119% | +$14.7M |
|
691
Labcorp
LH
$25.9B
| $27.8M | 0.02% |
186,373
+16,243
| +10% | +$2.47M |
|
692
Infosys
INFY
$50.7B
| $27.8M | 0.02% |
2,731,917
-1,680,699
| -38% | -$17.1M |
|
|
693
CALL
State Street Technology Select Sector SPDR ETF
XLK
$124B
| $27.7M | 0.02% |
736,400
+582,000
| +377% | +$21.3M |
|
694
F5
FFIV
$22.7B
| $27.7M | 0.02% |
139,085
+5,578
| +4% | +$1.02M |
|
695
Vornado Realty Trust
VNO
$7.38B
| $27.7M | 0.02% |
379,297
+74,937
| +25% | +$5.55M |
|
|
GAP
696
The Gap Inc
GAP
$7.37B
| $27.7M | 0.02% |
958,599
+387,291
| +68% | +$11.6M |
|
|
TFCFA
697
CALL
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
| $27.6M | 0.02% |
596,800
-197,700
| -25% | -$9.06M |
|
698
CALL
Chevron
CVX
$366B
| $27.4M | 0.02% |
224,200
+25,200
| +13% | +$3.06M |
|
699
PUT
Viatris
VTRS
$18.9B
| $27.2M | 0.02% |
743,700
-271,700
| -27% | -$10.2M |
|
700
Incyte
INCY
$24.4B
| $27.2M | 0.02% |
393,475
+63,806
| +19% | +$4.38M |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.